Nine Lots of IV Antibiotic Recalled — Physician’s First Watch
Nine Lots of IV Antibiotic Recalled
By the Editors
Nine lots of the intravenous antibacterial Cubicin (daptomycin 500 mg), used for skin and bloodstream infections, have been recalled because of complaints about foreign particulate matter in reconstituted vials.
The FDA notes that if administered intravenously, particulate matter can result in thromboembolism, including potentially fatal pulmonary embolism.
The affected lots were shipped between July and December 2013. To date, there have been no adverse events related to particulate matter in these vials.